{"name":"Microbion Corporation","slug":"microbion-corporation","ticker":"","exchange":"","domain":"","description":"Microbion Corporation is a biotechnology company focused on developing novel antimicrobial therapies to address unmet medical needs in infectious diseases. The company's lead candidates, MBN-101 and Topical Pravibismane, are currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQYm1ET2N1QW8xRGRaU1k5eHBnUmpsdHFlbFhYaXJmSW1XZmhLM2tHQXdreDgzdmtfSmQ2UUZBNUljLXZUcGZ2TDB5SHp2YWxlcERjV3Zxc0RpcDNPYnV2dFFJTjNFMjdDNFBaWml5SzNaa3ZsTHA1MGJ4d3VqVnFGVmI0WTZqTGFVUy12YXlqcEo1b3pnMnlISmFhTmlFeXNtRjdDbWJSVWJSYmRIbG9GM1RWYXZaQQ?oc=5","date":"2024-12-05","type":"pipeline","source":"Bloomberg.com","summary":"The Quest to Turn Human Waste Into Medicine - Bloomberg.com","headline":"The Quest to Turn Human Waste Into Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOc1U5dzVUUExkOEpEVFJWSjN0ZFdhSWNHWjljdWJJRXpIc2wwdjZta1FlTnFycTBJU3prY2k5THN6NGp6RGVCQnlMa29Kcm1oMDBKNFRwVVpRY201WWNURHctXzdPSG1ST0JIajRhOWVLOS1LRFdVV0ExNV95UHptam9nS3ZvbFhRSE1CdTdZVkdjS3FybjRWaFp2TE5LaHNXZk9ORl82VkFBZFp4QXotUlM1cXdPVjFXaThSbFl2YkJ2eVlZYVlUVElyaDZMZC1lejVqQm5TS1Z4M2ZUWG5nbHVHX3ZLcDBHQkdiQUkwYzRSbWJuWHlzNnpYQnFYWG10Y0hrdDQyY2hNUW90ekZDeDkxaXBwaWZab1lKZ1laMmw?oc=5","date":"2024-04-04","type":"trial","source":"PR Newswire","summary":"Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal - PR Newswire","headline":"Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in Interna","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-04-06","type":"patent","source":"Indian Pharma Post","summary":"Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections - Indian Pharma Post","headline":"Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOS3hRRUVVcm4wRkFSak95T1NEUkZ0d1Vqd2ozdzFNZmM5SDNHX0dSc3lZeGFnUnc4aHk3WFQyLS1Fbm9oNU5mUkZWdGhZNkxwaUx6Rk11QnRIbWwtX3JxMlI2VGRIbWtMSEdDc3ZDcGV5WG12OWFaRWNvUDQ3MW9wbTJCbVlsTmhPS0RWQWhUcnRsMTNYM0FJWXk4Qm5VT3VWWVlBM29IQmgzMV9Va0ZmbG1WenZBZ05YMTlUN0h6Y0tGc1VmZXRpQmV5eVJEUQ?oc=5","date":"2023-02-03","type":"pipeline","source":"PR Newswire","summary":"Microbion Corporation CEO to Present at the 2023 BIO CEO & Investor Conference - PR Newswire","headline":"Microbion Corporation CEO to Present at the 2023 BIO CEO & Investor Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPLVQwSWhkcTdGT3JXM1FKQlpERVpvQU4xTy1sNFByQVBiMWFnUkVxNjBpMHducTN1cVEwbnZaUGxranRPNU40emNrVTFPWnVRMW1JbkRIWWFQdWhuX28yMkJvXzFURlZqVHI0N0hjY2h6RVpidW9xeEh5dVZ0M19EaU55VzRRRTRSbjEyTGtLYlVhb1lHOWJYYlZNRXFKX0lKUXFqZS1IVXVjWldvRkt0ci05VlhGMXp3OVo2WHkyWFBGX0RIYl9memxMMUtBMnM?oc=5","date":"2020-06-11","type":"pipeline","source":"Healio","summary":"Pravibismane nets orphan drug designation for pulmonary infections in cystic fibrosis - Healio","headline":"Pravibismane nets orphan drug designation for pulmonary infections in cystic fibrosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFAyUDNZNm9mSEdsaEJteTVTVXpIM1dzbFpTaGFHVXpwZlE4UThrRmZlLTd0ZWFlYjViUkI4bWszUTRFLThuaEZPNmlucFEzR1Qydmc?oc=5","date":"2019-09-05","type":"pipeline","source":"Market.us","summary":"Bismuth Market Size, Share | CAGR of 5.3% - Market.us","headline":"Bismuth Market Size, Share | CAGR of 5.3%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQZkFTakxBem9jOEMyMDV2UG1kT05EYlRpaGxHQ2hsc0pOdTIycnJ5Sm84TE52T1ZxRTZnUjV4Ulk4ZzFCVDUzODV3ZXVVWmFJT01qLWhoZEw5d2JNb1JRSkVuYnVXSkpBMzl3WnlYdWNzOTNTOWd4X0FaU3RDSnNSRUhMMWhyVzB0dG1nVU5VZDNFZllDck9BaXJhRkoxY1oxREE2cGJvVm9VckcyOUx4Sml2b2dzN0NVcTRqVG10MVJRZjlpUVMtMGw3Y2h4NWYxeldVdUplUkFtTXA2WjJneUFYaFdUMVF1UnBubVVNVVRBVVFPYWJvWXJB?oc=5","date":"2019-01-10","type":"pipeline","source":"openPR.com","summary":"Diabetic Foot Ulcer Therapeutics - Key Players Analysis - openPR.com","headline":"Diabetic Foot Ulcer Therapeutics - Key Players Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOYnFNX2t5cXliQ0FZVkFrWE5MU0lEeWFSa0UxXzBxS3ZlRDdYQzZaUjJUTlBkNlF4NGQ3TjVqVmNlN09QVllvSVpxbGRPUndwRkMzcWc2NGVzZ3kyemdwWnp3bW9aQkJGNHpLVEYxdnNJVFhPdUtvQmNCVUk1YXBSSFVZallDSlFmTEtUZ080NnlMVlFkNk52eHp4VGJuRFVLZklVQlBJNWVXYndRSWxBaUVmdDdPR1U?oc=5","date":"2014-07-11","type":"pipeline","source":"Montana State University","summary":"Industry and MSU biofilm experts to weigh in on chronic infections during meeting - Montana State University","headline":"Industry and MSU biofilm experts to weigh in on chronic infections during meeting","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}